AU3359697A – Bone resorption inhibitors
– Google Patents
AU3359697A – Bone resorption inhibitors
– Google Patents
Bone resorption inhibitors
Info
Publication number
AU3359697A
AU3359697A
AU33596/97A
AU3359697A
AU3359697A
AU 3359697 A
AU3359697 A
AU 3359697A
AU 33596/97 A
AU33596/97 A
AU 33596/97A
AU 3359697 A
AU3359697 A
AU 3359697A
AU 3359697 A
AU3359697 A
AU 3359697A
Authority
AU
Australia
Prior art keywords
bone resorption
resorption inhibitors
inhibitors
bone
resorption
Prior art date
1996-07-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33596/97A
Inventor
Kazuhiko Aibe
Susumu Igarashi
Yasutaka Ishii
Ichio Noda
Osamu Noshiro
Yukihiro Takebayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-07-08
Filing date
1997-07-08
Publication date
1998-02-02
1997-07-08
Application filed by Yamanouchi Pharmaceutical Co Ltd
filed
Critical
Yamanouchi Pharmaceutical Co Ltd
1998-02-02
Publication of AU3359697A
publication
Critical
patent/AU3359697A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
C07K5/06—Dipeptides
C07K5/06139—Dipeptides with the first amino acid being heterocyclic
C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AU33596/97A
1996-07-08
1997-07-08
Bone resorption inhibitors
Abandoned
AU3359697A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
JP8-177955
1996-07-08
JP17795596
1996-07-08
PCT/JP1997/002357
WO1998001133A1
(en)
1996-07-08
1997-07-08
Bone resorption inhibitors
Publications (1)
Publication Number
Publication Date
AU3359697A
true
AU3359697A
(en)
1998-02-02
Family
ID=16040012
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU33596/97A
Abandoned
AU3359697A
(en)
1996-07-08
1997-07-08
Bone resorption inhibitors
Country Status (2)
Country
Link
AU
(1)
AU3359697A
(en)
WO
(1)
WO1998001133A1
(en)
Families Citing this family (28)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB9723407D0
(en)
1997-11-05
1998-01-07
Ciba Geigy Ag
Organic compounds
JP4594520B2
(en)
1998-03-19
2010-12-08
バーテックス ファーマシューティカルズ インコーポレイテッド
Caspase inhibitor
US6902721B1
(en)
1998-07-10
2005-06-07
Osteoscreen, Inc.
Inhibitors of proteasomal activity for stimulating bone growth
US6117870A
(en)
1998-11-12
2000-09-12
Fujirebio Kabushiki Kaisha
Cyclic amide derivatives
CN1362947A
(en)
1999-03-15
2002-08-07
Axys药物公司
N-cyanomethylamides as protease inhibitors
CA2385882C
(en)
1999-09-24
2009-11-24
Genentech, Inc.
Tyrosine derivatives
USRE39921E1
(en)
1999-10-07
2007-11-13
Smithkline Beecham Corporation
Chemical compounds
GB9923748D0
(en)
1999-10-07
1999-12-08
Glaxo Group Ltd
Chemical compounds
AU783145B2
(en)
1999-12-24
2005-09-29
F. Hoffmann-La Roche Ag
Nitrile derivatives as cathepsin K inhibitors
GB0003111D0
(en)
2000-02-10
2000-03-29
Novartis Ag
Organic compounds
PE20011350A1
(en)
2000-05-19
2002-01-15
Vertex Pharma
PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE)
GB0025354D0
(en)
2000-10-17
2000-11-29
Glaxo Group Ltd
Chemical compounds
EP1383748A2
(en)
2000-12-22
2004-01-28
Axys Pharmaceuticals, Inc.
Novel compounds and compositions as cathepsin inhibitors
US7030116B2
(en)
2000-12-22
2006-04-18
Aventis Pharmaceuticals Inc.
Compounds and compositions as cathepsin inhibitors
BR0212535A
(en)
2001-09-14
2004-10-19
Aventis Pharma Inc
Compounds and compositions as cathepsin inhibitors
US6977256B2
(en)
2001-11-14
2005-12-20
Aventis Pharmaceuticals Inc.
Compounds and compositions as cathepsin S inhibitors
GB0203022D0
(en)
2002-02-08
2002-03-27
Glaxo Group Ltd
Chemical compounds
EP1472222A1
(en)
2002-02-08
2004-11-03
Glaxo Group Limited
Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0203020D0
(en)
2002-02-08
2002-03-27
Glaxo Group Ltd
Chemical compounds
PT1855674E
(en)
*
2005-03-02
2014-10-08
Merck Canada Inc
Composition for inhibition of cathepsin k
JP3975226B2
(en)
2006-01-11
2007-09-12
生化学工業株式会社
Cycloalkylcarbonylamino acid derivative and process for producing the same
CA2636765C
(en)
2006-01-11
2014-03-18
Seikagaku Corporation
Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP4047365B2
(en)
2006-01-11
2008-02-13
生化学工業株式会社
Cycloalkanecarboxamide derivative and method for producing the same
JP4012239B2
(en)
2006-01-11
2007-11-21
生化学工業株式会社
Oxazolone derivatives
SI2421826T1
(en)
2009-04-20
2014-02-28
F. Hoffmann-La Roche Ag
Proline derivatives as cathepsin inhibitors
JP6006908B2
(en)
2010-11-05
2016-10-12
ブランダイス ユニバーシティBrandeis University
ICE inhibitory compounds and uses thereof
WO2014199645A1
(en)
2013-06-14
2014-12-18
生化学工業株式会社
α-OXOACYL AMINO-CAPROLACTAM BODY
US9481707B2
(en)
2013-06-14
2016-11-01
Seikagaku Corporation
α-oxoacyl amino-caprolactam derivative
Family Cites Families (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS58140026A
(en)
*
1982-01-14
1983-08-19
Toyo Jozo Co Ltd
Pharmaceutical having improved absorbability
JPS62129297A
(en)
*
1985-08-09
1987-06-11
Toyo Jozo Co Ltd
Calcitonin gene related peptide derivative
US5055451A
(en)
*
1986-12-22
1991-10-08
Syntex Inc.
Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
JP3613818B2
(en)
*
1994-10-06
2005-01-26
三菱ウェルファーマ株式会社
Tricoporin derivatives
EP0863915B1
(en)
*
1995-12-01
2000-02-02
Hoechst Marion Roussel, Inc.
Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
1997
1997-07-08
WO
PCT/JP1997/002357
patent/WO1998001133A1/en
active
Application Filing
1997-07-08
AU
AU33596/97A
patent/AU3359697A/en
not_active
Abandoned
Also Published As
Publication number
Publication date
WO1998001133A1
(en)
1998-01-15
Similar Documents
Publication
Publication Date
Title
AU3359697A
(en)
1998-02-02
Bone resorption inhibitors
AU2205997A
(en)
1998-05-29
Orthopedic implant
AU1224895A
(en)
1995-08-24
Bone anchor
AU3380397A
(en)
1998-01-05
Bone screw
AU5407598A
(en)
1998-06-10
Bone implant
AU2659997A
(en)
1997-10-29
Fixation devices
AU692846B2
(en)
1998-06-18
Bone plate
AU2001199A
(en)
1999-07-19
Bone plate
AU6412796A
(en)
1997-04-09
Osteosynthesis aid
AU4477897A
(en)
1998-04-17
Orthopedic device
AU5846498A
(en)
1998-11-26
Spinal implant
AU5855796A
(en)
1996-11-29
Methods for inhibiting bone loss
AU3140695A
(en)
1996-02-22
1h-indole-1-functional spla2 inhibitors
AU8782798A
(en)
1999-03-08
Self-clearing bone biting instrument
AU6493598A
(en)
1998-11-11
Biodegradable osteosynthesis implant
AU1036697A
(en)
1997-06-27
Surgical anchorage
AU4203297A
(en)
1998-02-20
The use of proteinase inhibitors for prevention or reduction of bone resorption
AU1486997A
(en)
1997-08-28
An agent promoting bone formation and inhibiting bone resorption
AU3459897A
(en)
1998-02-09
Differentiation inhibitor
AU6043096A
(en)
1996-12-24
Methods for minimizing bone loss
AUPN289395A0
(en)
1995-06-01
Intramedullary bone nail
AU7888498A
(en)
1998-07-31
Carcinogenesis inhibitors
AU3254097A
(en)
1998-01-14
An orthopedic bandage
AU5743396A
(en)
1996-11-29
Methods for inhibiting bone loss
AU2810497A
(en)
1997-11-12
Methods for inducing bone formation
None